Sarah J. Parsons mainly focuses on Cancer research, Proto-oncogene tyrosine-protein kinase Src, Tyrosine kinase, Receptor tyrosine kinase and Growth factor receptor. The Cancer research study combines topics in areas such as Receptor, Internal medicine, STAT protein and Endocrinology. Phosphorylation covers Sarah J. Parsons research in Proto-oncogene tyrosine-protein kinase Src.
Her research investigates the connection between Tyrosine kinase and topics such as Kinase that intersect with problems in Exocytosis, DNA-binding protein and Cancer cell. Her Receptor tyrosine kinase research includes elements of ROR1, Tropomyosin receptor kinase C and Mitogen-activated protein kinase. Her Growth factor receptor study incorporates themes from Insulin-like growth factor 1 receptor and ERBB3.
Cancer research, Proto-oncogene tyrosine-protein kinase Src, Cell biology, Phosphorylation and Tyrosine kinase are her primary areas of study. Her Cancer research research includes themes of Endocrinology, Carcinogenesis, Internal medicine, LNCaP and Growth factor receptor. Her studies deal with areas such as ERBB3, Epidermal growth factor receptor and Tyrosine phosphorylation as well as Proto-oncogene tyrosine-protein kinase Src.
While the research belongs to areas of Cell biology, Sarah J. Parsons spends her time largely on the problem of Cytokinesis, intersecting her research to questions surrounding Guanine nucleotide exchange factor. Her Phosphorylation research incorporates themes from Receptor, Epidermal growth factor, Tyrosine, Molecular biology and Kinase. Her study in Tyrosine kinase is interdisciplinary in nature, drawing from both Receptor tyrosine kinase, Estrogen receptor and Transfection.
Sarah J. Parsons focuses on Cell biology, Cancer research, Prostate cancer, Internal medicine and Androgen receptor. Her study of Phosphorylation is a part of Cell biology. Her Cancer research study integrates concerns from other disciplines, such as Tyrosine and Protein kinase A.
Her work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Oncology. Her research in Endocrinology intersects with topics in Tyrosine kinase, Estrogen receptor beta, Receptor tyrosine kinase and Estrogen receptor alpha. Her Integrin research also works with subjects such as
Her main research concerns Cell biology, Prostate cancer, Androgen receptor, Cell growth and Neurosphere. In the field of Cell biology, her study on Focal adhesion, Proto-oncogene tyrosine-protein kinase Src and Protein kinase R overlaps with subjects such as ULK1. Sarah J. Parsons combines subjects such as Signal transduction, Protein tyrosine phosphatase, Apoptosis, Annexin and Molecular biology with her study of Prostate cancer.
The study incorporates disciplines such as 2-Methoxyestradiol, Gene knockdown, Mdm2 and Small interfering RNA in addition to Androgen receptor. Sarah J. Parsons interconnects Oncomir, Stem cell and Apoptosis Regulator in the investigation of issues within Cell growth.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Roy Garcia;Tammy L Bowman;Guilian Niu;Hua Yu.
C-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function
Jacqueline S. Biscardi;Ming Chei Maa;David A. Tice;Michael E. Cox.
Journal of Biological Chemistry (1999)
Mechanism of biological synergy between cellular Src and epidermal growth factor receptor
David A. Tice;Jacqueline S. Biscardi;Amanda L. Nickles;Sarah J. Parsons.
Proceedings of the National Academy of Sciences of the United States of America (1999)
Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways
J Thomas Parsons;Sarah J Parsons.
Current Opinion in Cell Biology (1997)
Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers.
Ming Chei Maa;Tzeng Horng Leu;Deborah J. Mccarley;Randall C. Schatzman.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Tyrosine kinase signalling in breast cancer: Epidermal growth factor receptor and c-Src interactions in breast cancer
Jacqueline S Biscardi;Rumey C Ishizawar;Corinne M Silva;Sarah J Parsons.
Breast Cancer Research (2000)
c-Src, receptor tyrosine kinases, and human cancer.
Jacqueline S. Biscardi;David A. Tice;Sarah J. Parsons.
Advances in Cancer Research (1999)
c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation.
Jin-Hong Chang;Satinder Gill;Jeffrey Settleman;Sarah J. Parsons.
Journal of Cell Biology (1995)
Phosphorylation of Y845 on the Epidermal Growth Factor Receptor Mediates Binding to the Mitochondrial Protein Cytochrome c Oxidase Subunit II
Julie L. Boerner;Michelle L. Demory;Corinne Silva;Sarah J. Parsons.
Molecular and Cellular Biology (2004)
Acquisition of Neuroendocrine Characteristics by Prostate Tumor Cells Is Reversible: Implications for Prostate Cancer Progression
Michael E. Cox;Paul D. Deeble;Saquib Lakhani;Sarah J. Parsons.
Cancer Research (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: